Cargando…

Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release

BACKGROUND: Treatment multiple tumors by immune therapy can be achieved by mobilizing both innate and adaptive immunity. The programmed death ligand 1 (PD-L1; or CD274, B7-H1) is a critical “don't find me” signal to the adaptive immune system. Equally CD47 is a critical “don't eat me” sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lian, Shu, Xie, Ruizhi, Ye, Yuying, Xie, Xiaodong, Li, Shuhui, Lu, Yusheng, Li, Bifei, Cheng, Yunlong, Katanaev, Vladimir L., Jia, Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491392/ https://www.ncbi.nlm.nih.gov/pubmed/30878596 http://dx.doi.org/10.1016/j.ebiom.2019.03.018

Ejemplares similares

Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
por: Lian, Shu, et al.
Publicado: (2019)

Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
por: Lian, Shu, et al.
Publicado: (2019)

NOL7 facilitates melanoma progression and metastasis
por: Li, Yumei, et al.
Publicado: (2021)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
por: Kauder, Steven E., et al.
Publicado: (2018)

Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271
por: Shen, Weiyu, et al.
Publicado: (2019)

Tumor-derived Exosome Promotes Metastasis via Altering its Phenotype and Inclusions
por: Zhou, Yu, et al.
Publicado: (2021)

CD47-blocking therapies stimulate macrophage cytokine secretion and are effective in a model of peritoneal carcinomatosis
por: Weiskopf, Kipp, et al.
Publicado: (2015)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules
por: Elemam, Noha Mousaad, et al.
Publicado: (2017)

CD47/SIRPα axis: bridging innate and adaptive immunity
por: van Duijn, Anneloes, et al.
Publicado: (2022)

Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis
por: Xie, Renjian, et al.
Publicado: (2022)

Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2019)

Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles
por: Xie, Xiaodong, et al.
Publicado: (2020)

Host MKRN1-Mediated Mycobacterial PPE Protein Ubiquitination Suppresses Innate Immune Response
por: Dou, Yafeng, et al.
Publicado: (2022)

In vivo Characterization of Plasmodium berghei P47 (Pbs47) as a Malaria Transmission-Blocking Vaccine Target
por: Yenkoidiok-Douti, Lampouguin, et al.
Publicado: (2020)

The Generation of Dual-Targeting Fusion Protein PD-L1/CD47 for the Inhibition of Triple-Negative Breast Cancer
por: Bian, Yanlin, et al.
Publicado: (2022)

CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
por: Voets, Erik, et al.
Publicado: (2019)

The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors
por: Wang, Min, et al.
Publicado: (2021)

Cytokine signaling in the differentiation of innate effector cells
por: Huang, Hua, et al.
Publicado: (2013)

Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention
por: Wang, Jie, et al.
Publicado: (2021)

Correction to: Embedding similarities between embryos and circulating tumor cells: fundamentals of abortifacients used for cancer metastasis chemoprevention
por: Wang, Jie, et al.
Publicado: (2021)

Blocking the PD-1/PD-L1 axis enhanced cisplatin chemotherapy in osteosarcoma in vitro and in vivo
por: Liu, Xiaoqiang, et al.
Publicado: (2019)

Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
por: Zhao, Yan, et al.
Publicado: (2017)

Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
por: Hu, Jinyang, et al.
Publicado: (2020)

Oxidation of Innate Immune Checkpoint CD47 on Cancer Cells with Non-Thermal Plasma
por: Lin, Abraham, et al.
Publicado: (2021)

Acidic Cannabinoids Suppress Proinflammatory Cytokine Release by Blocking Store-operated Calcium Entry
por: Faouzi, Malika, et al.
Publicado: (2022)

Cancer metastasis chemoprevention prevents circulating tumour cells from germination
por: Xie, Xiaodong, et al.
Publicado: (2022)

Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4
por: Jiang, Chunjuan, et al.
Publicado: (2021)

Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma
por: Zhang, Wan, et al.
Publicado: (2019)

Identification and Functional Analysis of Cytokine-Like Protein CLEC-47 in Caenorhabditis elegans
por: Pan, Wen, et al.
Publicado: (2021)

Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection
por: Cham, Lamin B., et al.
Publicado: (2020)

EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release
por: Suh, Koung Jin, et al.
Publicado: (2017)

Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal
por: Li, Chang, et al.
Publicado: (2022)

Blocking CD47 Shows Superior Anti-tumor Therapeutic Effects of Bevacizumab in Gastric Cancer
por: Shi, Chenyang, et al.
Publicado: (2022)

CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis
por: Navarathna, Dhammika H. M. L. P., et al.
Publicado: (2015)

Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia
Publicado: (1993)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6abbr8p49jdb9le336a42g3pj1